Thai Cannabis Industry Thrown Into Chaos as Government Aims to Recriminalize Weed
The new rules have thrown the fledgling industry into chaos and sparked criticism from pro-cannabis activists, who championed liberalization as a way to boost Thailand's wellness and tourism sectors. Dispensaries must now sell only cannabis produced by farms that have obtained the 'Good Agricultural and Collection Practices' certifications issued by the government, and amounts are capped at a 30-day supply per customer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Vext to Announce Financial Results for Q2 2025 on August 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before market open on August 20, 2025. The Company will host a conference call and webcast on the same day, Wednesday, August 20, 2025, at 08:00 a.m. ET to discuss the financial results. CONFERENCE CALL DETAILS Date: August 20, 2025 | Time: 8:00 am E.T. Participant Dial-in: +1-647-849-3159 or 1-833-752-3966 Replay Dial-in: +1-412-317-0088 or 1-855-669-9658 Conference ID: 10202130 Playback #: 6656822 (Expires on September 3, 2025) Listen to webcast: A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@ About Vext Science, Inc. Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value. Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at and connect with Vext on Twitter/X and LinkedIn. For more details on the Vapen brand:Vapen website: @vapenFacebook: @vapenbrands Forward-Looking Statements Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements. Forward-looking statements may include, without limitation, statements regarding the expected filing date of the financial results, future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release. Eric Offenberger Chief Executive Officer844-211-3725 For further information: Jonathan Ross, Vext Investor SOURCE: Vext Science, Inc To view the source version of this press release, please visit
Yahoo
3 hours ago
- Yahoo
Singapore's ABC Impact to invest in AC Health
Singapore-based investor ABC Impact is set to make a strategic investment in AC Health, marking its first direct entry into the healthcare sector of the Philippines. ABC Impact will acquire an approximately 16% minority stake in AC Health, with the primary capital investment being used to support the company's aim of creating an integrated healthcare ecosystem to benefit the people of the country. This investment will strengthen AC Health's growth across its core pillars, including hospitals, retail pharmacies and multi-speciality clinics. AC Health plans to expand its network to at least ten hospitals, 300 clinics, and 1,150 pharmacies by 2027. This expansion will be achieved through targeted acquisitions and organic growth, assisted by the new capital from ABC Impact. With its focus on Asia, ABC Impact brings regional insights and networks to the partnership. The investor has made healthcare investments in China, India, and Vietnam and sees potential for collaboration and knowledge-sharing that could enhance its care model in the Philippines. AC Health president and CEO Paolo Borromeo said: 'ABC Impact's investment reinforces the strength of our integrated model and our commitment to making healthcare more inclusive. 'This partnership creates valuable opportunities for knowledge exchange, technology transfer, and the adoption of global best practices, further enabling AC Health to raise the bar in care quality, patient safety, and operational efficiency as it moves toward world-class standards.' This move combines the integrated delivery network of AC Health with ABC Impact's experience in investing in inclusive healthcare solutions. ABC Impact also looks to build on its regional track record of purpose-driven capital infusions, which encompasses companies such as DCDC Kidney Care in India, Kim Dental in Vietnam, and clinical research organisation HiRo, which operates across the Asia Pacific and the US. In addition, the move strengthens the partnership between the Ayala Group, which AC Health is a part of, and the Temasek ecosystem, which supports ABC Impact. For this transaction, BofA Securities served as the exclusive financial adviser to AC Health. The completion of ABC Impact's investment is contingent upon the fulfilment of closing conditions. "Singapore's ABC Impact to invest in AC Health" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
5 hours ago
- Yahoo
Indonesia eyes 'sovereign AI fund' to drive development, document shows
JAKARTA (Reuters) -Authorities overseeing the development of artificial intelligence in Indonesia have proposed a "sovereign AI fund" to finance the archipelago's ambitions to become a regional hub for the fast-growing technology, a government document showed. Last month, Reuters reported that Southeast Asia's largest economy would release its first national roadmap on AI in a bid to attract foreign investment as it looks to join the global AI and chip-making race. The race has seen neighbouring Malaysia secure billions of dollars from global tech firms seeking to build critical infrastructure to meet growing demand for cloud and AI services. The Indonesia strategy, released in the form of a 179-page white paper seen by Reuters, recommends, among other things, a sovereign AI fund mainly handled by the country's new sovereign wealth fund Danantara Indonesia, which controls over $900 billion in assets. Danantara Indonesia did not immediately reply to a request for comment. The paper did not specify the amount that would be needed, but estimated a 2027 to 2029 timeline to set up the fund, and a public-private model to finance Indonesia's AI push. It also suggests increasing fiscal incentives for domestic investors in AI, without providing details. The strategy paper, which the communications and digital ministry said still awaits public feedback before the final draft, maps Indonesia's computational readiness for AI and makes recommendations for AI-related policy strategies until 2030. "Indonesia right now is in the early stages of AI adoption," the document reads. Industry players including Chinese giant Huawei and Indonesia's biggest technology company GoTo contributed to the report. An April report by the Boston Consulting Group said ASEAN nations were positioned for substantial AI-driven gains, with GDP contributions ranging from 2.3% to 3.1% by 2027, and Indonesia could see the highest impact in terms of absolute gross domestic output growth. The roadmap also details challenges for Indonesia including a lack of talent, low research funding, uneven connectivity outside big cities, risks of misinformation and data leaks. Global tech companies have courted the AI drive in Indonesia, including Nvidia and Microsoft. Sign in to access your portfolio
